About Peter Kiener
Peter Kiener is a chair at Allotera Therapeutics.
Peter Kiener first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Kiener in the role, so the role may have started earlier or lasted longer.
Allotera Therapeutics, Inc.
Chair
2021 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
Key Colleagues at Startups
The people Peter Kiener works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
NM
Natalie Mount
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director